U.S., April 29 -- ClinicalTrials.gov registry received information related to the study (NCT06387368) titled 'Clinical Study of Huaier Granule in the Treatment of Unresectable Pancreatic Cancer' on April 23.
Brief Summary: This is a prospective, multicenter, randomized, open, parallel controlled clinical study to evaluate the efficacy and safety of Huaier Granules combined with capecitabine in the treatment of unresectable pancreatic cancer.
Study Type: Interventional
Condition: Pancreatic Cancer Non-resectable
Intervention: * Drug: Huaier Granule
Huaier Granules: Oral administration, 10g once, 3 times a day. Capecitabine: oral administration, 1250mg/m^2, twice a day (2500mg/m^2/d), day 1-14, once every 3 weeks.
Other Name: Z20000109#...